Market Overview:
The global tilmicosin and derivatives market is expected to grow at a CAGR of 5.5% from 2018 to 2030. Tilmicosin is a macrolide antibiotic used in the treatment of respiratory tract infections, pneumonia, and other diseases caused by Gram-positive bacteria in animals. The tilmicosin premixes are used as feed additives for the prevention and control of coccidiosis in poultry and swine. North America dominates the global tilmicosin and derivatives market, followed by Europe, Asia Pacific, Latin America, and Middle East & Africa. The growth of the tilmicosin and derivatives market is mainly driven by rising demand for animal drugs due to increasing population of livestock across the globe. Additionally, growing awareness about animal health among farmers is also propelling the growth of this market.
Product Definition:
Tilmicosin is a macrolide antibiotic used in veterinary medicine. Tilmicosin and its derivatives are important in the treatment of respiratory infections, including pneumonia, caused by susceptible bacteria.
Tilmicosin:
Tilmicosin is a first-generation anti-microbial topical antibiotic. It works by killing sensitive bacteria, mainly in the skin. Tilmicosin has been approved for the treatment of acne rosacea and bacillary uremia (BACU) and is under clinical investigation for the treatment of atopic dermatitis, impetigo contagiosa, and diabetic foot ulcers. The product was developed by Dr.
Tilmicosin Premix:
Tilmicosin is a type of medicine used to treat bacterial infections in the skin. It works by killing the bacteria that causes acne. Tilmicosin premix is an ointment containing tilycloxacillin and zinc oxide used for the treatment of mild-to-moderate acne rosacea.
Tilmicosin Ophthalmic Solution (TOS) - 2% contains tilycloxacillin, which is mainly prescribed for bacterial keratitis.
Application Insights:
The animal drugs segment led the global tilmicosin and derivatives market in 2017. This is attributed to rising demand for anti-inflammatory, analgesic, antipyretic and antidiabetic products from pet animals. Tilmicosin is used as an active pharmaceutical ingredient (API) in several animal drugs including FELINE VETERINARY DRUGS (FV), EQUINE VETERINARY DRUGS (QV), ANTIPYRETIC/ANALGESIC AGENTS FOR PET ANIMALS & HORSES (PAH) and TILMICOSIN PEPTIDE FOR HUMANS.
In addition, increasing awareness among people about their health conditions has resulted in a growing need for medicines that cure diseases without causing harm to the human body has driven the demand for tilmicosin-based medicines over recent years.
Regional Analysis:
North America dominated the global market in 2017. The growth of this region can be attributed to the presence of key manufacturers such as Cargill, Inc.; Roquette; and FMC Corporation. These companies are engaged in extensive R&D activities to develop novel tilmicosin derivatives for use in pharmaceuticals, feed additives and other industries.
Growth Factors:
- Increasing prevalence of respiratory tract infections: The global prevalence of respiratory tract infections is increasing due to the changing lifestyle and environmental conditions. This is expected to drive the demand for tilmicosin and its derivatives over the forecast period.
- Rising awareness about antibiotic resistance: There is a growing awareness among people about antibiotic resistance, which is driving them to seek better alternatives such as tilmicosin and its derivatives. This is expected to boost the market growth during the forecast period.
- Technological advancements in drug delivery systems: The technological advancements in drug delivery systems are providing new opportunities for tilmicosin and its derivatives market growth over the forecast period. These advancements are helping in improving patient compliance, thus propelling market growth further.
Scope Of The Report
Report Attributes
Report Details
Report Title
Tilmicosin and Derivatives Market Research Report
By Type
Tilmicosin, Tilmicosin Premix
By Application
Animal Drugs, Animal Feed Additives
By Companies
Elanco, Huvepharma, Tairui, Lukang Shelile, Shangqiu IGM, Hubei CAHIC, Hubei Longxiang, Hubei Masteam, Shandong Fangming, Qilu Synva
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
159
Number of Tables & Figures
112
Customization Available
Yes, the report can be customized as per your need.
Global Tilmicosin and Derivatives Market Report Segments:
The global Tilmicosin and Derivatives market is segmented on the basis of:
Types
Tilmicosin, Tilmicosin Premix
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Animal Drugs, Animal Feed Additives
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Elanco
- Huvepharma
- Tairui
- Lukang Shelile
- Shangqiu IGM
- Hubei CAHIC
- Hubei Longxiang
- Hubei Masteam
- Shandong Fangming
- Qilu Synva
Highlights of The Tilmicosin and Derivatives Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tilmicosin
- Tilmicosin Premix
- By Application:
- Animal Drugs
- Animal Feed Additives
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tilmicosin and Derivatives Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Tilmicosin is a synthetic opioid analgesic that is used to relieve pain. Tilmicosin and its derivatives are also used as anti-inflammatory agents.
Some of the major players in the tilmicosin and derivatives market are Elanco, Huvepharma, Tairui, Lukang Shelile, Shangqiu IGM, Hubei CAHIC, Hubei Longxiang, Hubei Masteam, Shandong Fangming, Qilu Synva.
The tilmicosin and derivatives market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Tilmicosin and Derivatives Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Tilmicosin and Derivatives Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Tilmicosin and Derivatives Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Tilmicosin and Derivatives Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Tilmicosin and Derivatives Market Size & Forecast, 2018-2028 4.5.1 Tilmicosin and Derivatives Market Size and Y-o-Y Growth 4.5.2 Tilmicosin and Derivatives Market Absolute $ Opportunity
Chapter 5 Global Tilmicosin and Derivatives Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Tilmicosin and Derivatives Market Size Forecast by Type
5.2.1 Tilmicosin
5.2.2 Tilmicosin Premix
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Tilmicosin and Derivatives Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Tilmicosin and Derivatives Market Size Forecast by Applications
6.2.1 Animal Drugs
6.2.2 Animal Feed Additives
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Tilmicosin and Derivatives Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Tilmicosin and Derivatives Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Tilmicosin and Derivatives Analysis and Forecast
9.1 Introduction
9.2 North America Tilmicosin and Derivatives Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Tilmicosin and Derivatives Market Size Forecast by Type
9.6.1 Tilmicosin
9.6.2 Tilmicosin Premix
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Tilmicosin and Derivatives Market Size Forecast by Applications
9.10.1 Animal Drugs
9.10.2 Animal Feed Additives
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Tilmicosin and Derivatives Analysis and Forecast
10.1 Introduction
10.2 Europe Tilmicosin and Derivatives Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Tilmicosin and Derivatives Market Size Forecast by Type
10.6.1 Tilmicosin
10.6.2 Tilmicosin Premix
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Tilmicosin and Derivatives Market Size Forecast by Applications
10.10.1 Animal Drugs
10.10.2 Animal Feed Additives
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Tilmicosin and Derivatives Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Tilmicosin and Derivatives Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Tilmicosin and Derivatives Market Size Forecast by Type
11.6.1 Tilmicosin
11.6.2 Tilmicosin Premix
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Tilmicosin and Derivatives Market Size Forecast by Applications
11.10.1 Animal Drugs
11.10.2 Animal Feed Additives
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Tilmicosin and Derivatives Analysis and Forecast
12.1 Introduction
12.2 Latin America Tilmicosin and Derivatives Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Tilmicosin and Derivatives Market Size Forecast by Type
12.6.1 Tilmicosin
12.6.2 Tilmicosin Premix
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Tilmicosin and Derivatives Market Size Forecast by Applications
12.10.1 Animal Drugs
12.10.2 Animal Feed Additives
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Tilmicosin and Derivatives Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Tilmicosin and Derivatives Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Tilmicosin and Derivatives Market Size Forecast by Type
13.6.1 Tilmicosin
13.6.2 Tilmicosin Premix
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Tilmicosin and Derivatives Market Size Forecast by Applications
13.10.1 Animal Drugs
13.10.2 Animal Feed Additives
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Tilmicosin and Derivatives Market: Competitive Dashboard
14.2 Global Tilmicosin and Derivatives Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Elanco
14.3.2 Huvepharma
14.3.3 Tairui
14.3.4 Lukang Shelile
14.3.5 Shangqiu IGM
14.3.6 Hubei CAHIC
14.3.7 Hubei Longxiang
14.3.8 Hubei Masteam
14.3.9 Shandong Fangming
14.3.10 Qilu Synva